BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37968164)

  • 1. Establishing the role of muscle ultrasound as an imaging biomarker in facioscapulohumeral muscular dystrophy.
    Vincenten SCC; Teeselink S; Voermans NC; van Engelen BGM; Mul K; van Alfen N
    Neuromuscul Disord; 2023 Dec; 33(12):936-944. PubMed ID: 37968164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy.
    Veltsista D; Chroni E
    Acta Neurol Scand; 2021 Aug; 144(2):216-220. PubMed ID: 33844852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.
    Gijsbertse K; Goselink R; Lassche S; Nillesen M; Sprengers A; Verdonschot N; van Alfen N; de Korte C
    Ultrasound Med Biol; 2017 Nov; 43(11):2537-2545. PubMed ID: 28764967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle ultrasound is a responsive biomarker in facioscapulohumeral dystrophy.
    Goselink RJM; Schreuder THA; Mul K; Voermans NC; Erasmus CE; van Engelen BGM; van Alfen N
    Neurology; 2020 Apr; 94(14):e1488-e1494. PubMed ID: 32132178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
    Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
    Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
    J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.
    Leung DG; Carrino JA; Wagner KR; Jacobs MA
    Muscle Nerve; 2015 Oct; 52(4):512-20. PubMed ID: 25641525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
    Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
    Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy.
    Wang LH; Shaw DWW; Faino A; Budech CB; Lewis LM; Statland J; Eichinger K; Tapscott SJ; Tawil RN; Friedman SD
    BMC Musculoskelet Disord; 2021 Mar; 22(1):262. PubMed ID: 33691664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
    Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
    Hamel J; Lee P; Glenn MD; Burka T; Choi IY; Friedman SD; Shaw DWW; McCalley A; Herbelin L; Dimachkie MM; Lemmers R; van der Maarel SM; Barohn RJ; Tawil R; Statland JM
    Muscle Nerve; 2020 May; 61(5):644-649. PubMed ID: 31884698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
    Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
    Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
    Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
    Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
    Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
    Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complementary use of muscle ultrasound and MRI in FSHD: Early versus later disease stage follow-up.
    Vincenten SCC; Voermans NC; Cameron D; van Engelen BGM; van Alfen N; Mul K
    Clin Neurophysiol; 2024 Mar; ():. PubMed ID: 38521678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skeletal muscle MRI of lower limbs in patients with facioscapulohumeral dystrophy].
    Ma MM; Song J; Zhang JW; Gao L; Pang M; Li G; Fu J
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(9):675-679. PubMed ID: 30831616
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
    Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
    J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
    Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
    Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.
    Mellion ML; Widholm P; Karlsson M; Ahlgren A; Tawil R; Wagner KR; Statland JM; Wang L; Shieh PB; van Engelen BGM; Kools J; Ronco L; Odueyungbo A; Jiang J; Han JJ; Hatch M; Towles J; Leinhard OD; Cadavid D
    Neurology; 2022 Aug; 99(9):e877-e889. PubMed ID: 35750498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.